Page last updated: 2024-11-05

an 1

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

amphetaminil: a supposedly insoluble amphetamine complex that may release amphetamine; proposed as central nervous system stimulant; minor desriptor (78-86); on line & INDEX MEDICUS search AMPHETAMINES (75-86); RN given refers to parent compound [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID28615
CHEMBL ID2104064
CHEBI ID135022
SCHEMBL ID160285
MeSH IDM0263087

Synonyms (54)

Synonym
acetonitrile, ((alpha-methylphenethyl)amino)phenyl-
brn 2056148
amfetaminilum [inn-latin]
benzeneacetonitrile, alpha-((1-methyl-2-phenylethyl)amino)-
einecs 241-560-8
alpha-phenyl-alpha(beta-phenylisopropylamino)acetonitrile
alpha-phenyl-alpha-(1-phenylisopropyl)aminoacetonitrile
amfetaminil
2-((alpha-methylphenethyl)amino)-2-phenylacetonitril
n-(alpha-methylphenethyl)-2-phenylglycinonitrile
amfetaminilo [inn-spanish]
amfetaminil [inn]
n-(beta-phenylisopropyl)-alpha-aminophenylacetonitrile
((alpha-methylphenethyl)amino)phenylacetonitrile
an 1 (van)
alpha-phenyl-alpha-n-(1-phenylisopropyl)aminoacetonitrile
alpha-phenyl-alpha-(1-methyl-2-phenyl)ethylaminoacetonitrile
nsc 67172
benzeneacetonitrile, .alpha.-[(1-methyl-2-phenylethyl)amino]-
aponeuron
.alpha.-phenyl-.alpha.-(1-phenylisopropyl)aminoacetonitrile
17590-01-1
an 1
acetonitrile, [(.alpha.-methylphenethyl)amino]phenyl-
nsc67172
n-(.beta.-phenylisopropyl)-.alpha.-aminophenylacetonitrile
amphetaminil
nsc-67172
an 1 (pharmaceutical)
dl-amphetaminil
D07446
an 1 (tn)
amfetaminil (inn)
NCIOPEN2_003034
CHEBI:135022
2-phenyl-2-(1-phenylpropan-2-ylamino)acetonitrile
unii-0xu0v77jve
amfetaminilo
0xu0v77jve ,
amfetaminilum
CHEMBL2104064
SCHEMBL160285
amfetaminil [mart.]
amfetaminil [who-dd]
amphetaminil [mi]
.alpha.-phenyl-.alpha.(.beta.-phenylisopropylamino)acetonitrile
NFHVTCJKAHYEQN-UHFFFAOYSA-N
n-(.alpha.-methylphenethyl)-2-phenylglycinonitrile
[(.alpha.-methylphenethyl)amino]phenylacetonitrile
[(1-methyl-2-phenylethyl)amino](phenyl)acetonitrile #
.alpha.-phenyl-.alpha.-(1-methyl-2-phenyl)ethylaminoacetonitrile
.alpha.-phenyl-.alpha.-n-(1-phenylisopropyl)aminoacetonitrile
Q474630
DTXSID80864783
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
amphetaminesAmines that constitute a class of central nervous system stimulants based on the structure of the parent amphetamine 1-phenylpropan-2-amine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (22.22)18.7374
1990's4 (44.44)18.2507
2000's3 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 120.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index120.15 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.52 (4.65)
Search Engine Demand Index215.13 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (120.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (22.22%)5.53%
Reviews3 (33.33%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other4 (44.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]